Status:
RECRUITING
Cell-free DNA in Acute Stroke
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
Cell-free DNA (cfDNA) is an important pro-inflammatory and prothrombotic mediator. With this study the investigators aim to gain new insights into the role of cfDNA in stroke and to perform a combined...
Eligibility Criteria
Inclusion
- Acute ischemic stroke due to large vessel occlusion (LVO) who require mechanical thrombectomy (detected in CT-Scan or MRI-Scan)
- 18 years of age
Exclusion
- Patients currently undergoing immunological therapies.
- Patients with immunological diseases
- Patients with systemic infections at the time of admission
Key Trial Info
Start Date :
March 30 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06928675
Start Date
March 30 2025
End Date
September 1 2026
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Switzerland, 4031